News by Tag: Generics Market Us
US Generic Drugs to Grow Strongly in Future
May 3, 2012
With blockbuster drugs going off-patents, the US generic drugs sector will grow at a CAGR of around 10% during 2010-2013, says RNCOS.
May 3, 2012
With blockbuster drugs going off-patents, the US generic drugs sector will grow at a CAGR of around 10% during 2010-2013, says RNCOS.
Antidepressants to Strengthen US Generics Market
March 5, 2012
Backed by patent expiration and desire to reduce healthcare cost, the US generic market is likely to grow at a CAGR of 10% during 2010-2013, says RNCOS.
March 5, 2012
Backed by patent expiration and desire to reduce healthcare cost, the US generic market is likely to grow at a CAGR of 10% during 2010-2013, says RNCOS.
US Generics Market Heading for Stupendous Growth
September 16, 2011
With key blockbuster drugs going off-patent in coming years, generics will account for around 80% of the total number of prescriptions dispensed in the US, says RNCOS in its latest report.
September 16, 2011
With key blockbuster drugs going off-patent in coming years, generics will account for around 80% of the total number of prescriptions dispensed in the US, says RNCOS in its latest report.
US Generics Market Poised for Stupendous Growth
July 20, 2011
Backed by factors like patent expiration of drugs and aging population, the US generics market will grow at a CAGR of 10% during 2010-2013, says RNCOS.
July 20, 2011
Backed by factors like patent expiration of drugs and aging population, the US generics market will grow at a CAGR of 10% during 2010-2013, says RNCOS.
Proton Pump Inhibitors to Boost the US Generics Market
July 13, 2011
Backed by patent expires on blockbuster drugs and the government support, the US generics drugs market will grow at a CAGR of 10% during 2010-2013.
July 13, 2011
Backed by patent expires on blockbuster drugs and the government support, the US generics drugs market will grow at a CAGR of 10% during 2010-2013.
Antipsychotics to Drive the US Generics Market
June 21, 2011
With the major drugs going off-patent and government promotion on rise, the US generics market has crossed the mark of US$ 80 Billion in 2010.
June 21, 2011
With the major drugs going off-patent and government promotion on rise, the US generics market has crossed the mark of US$ 80 Billion in 2010.
US Generics Market to Witness Dynamic Expansion
March 23, 2011
Backed by factors, such as government support and patent expiration of branded drugs, the US generics market will grow at the CAGR of around 10% during 2010-2013, says RNCOS.
March 23, 2011
Backed by factors, such as government support and patent expiration of branded drugs, the US generics market will grow at the CAGR of around 10% during 2010-2013, says RNCOS.
US Generics Market to Advance on Government Support
February 15, 2011
Backed by factors, like patent expiry of blockbuster drugs and heavy investments from the government, the US generics market will grow at the CAGR of around 10% during 2010-2012.
February 15, 2011
Backed by factors, like patent expiry of blockbuster drugs and heavy investments from the government, the US generics market will grow at the CAGR of around 10% during 2010-2012.